Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky.

Liu J, Murali T, Yu T, Liu C, Sivakumaran TA, Moseley HNB, Zhulin IB, Weiss HL, Durbin EB, Ellingson SR, Liu J, Huang B, Hallahan BJ, Horbinski CM, Hodges K, Napier DL, Bocklage T, Mueller J, Vanderford NL, Fardo DW, Wang C, Arnold SM.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):348-356. doi: 10.1158/1055-9965.EPI-17-0984. Epub 2018 Oct 30.

PMID:
30377206
2.

Multiplatform-based molecular subtypes of non-small-cell lung cancer.

Chen F, Zhang Y, Parra E, Rodriguez J, Behrens C, Akbani R, Lu Y, Kurie JM, Gibbons DL, Mills GB, Wistuba II, Creighton CJ.

Oncogene. 2017 Mar;36(10):1384-1393. doi: 10.1038/onc.2016.303. Epub 2016 Oct 24.

3.

Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis.

Kind M, Klukowska-Rötzler J, Berezowska S, Arcaro A, Charles RP.

PLoS One. 2017 Oct 31;12(10):e0187308. doi: 10.1371/journal.pone.0187308. eCollection 2017.

4.

Comprehensive analysis of oncogenic mutations in lung squamous cell carcinoma with minor glandular component.

Pan Y, Wang R, Ye T, Li C, Hu H, Yu Y, Zhang Y, Wang L, Luo X, Li H, Li Y, Shen L, Sun Y, Chen H.

Chest. 2014 Mar 1;145(3):473-479. doi: 10.1378/chest.12-2679.

PMID:
24158231
5.

Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.

Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, Malloff CA, Campbell J, Williams AC, Hwang D, Zhu CQ, Buys TP, Yee J, English JC, Macaulay C, Tsao MS, Gazdar AF, Minna JD, Lam S, Lam WL.

PLoS Med. 2010 Jul 27;7(7):e1000315. doi: 10.1371/journal.pmed.1000315.

6.

Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.

Lockwood WW, Wilson IM, Coe BP, Chari R, Pikor LA, Thu KL, Solis LM, Nunez MI, Behrens C, Yee J, English J, Murray N, Tsao MS, Minna JD, Gazdar AF, Wistuba II, MacAulay CE, Lam S, Lam WL.

PLoS One. 2012;7(5):e37775. doi: 10.1371/journal.pone.0037775. Epub 2012 May 21.

7.

New developments in the treatment of squamous cell lung cancer.

Filipits M.

Curr Opin Oncol. 2014 Mar;26(2):152-8. doi: 10.1097/CCO.0000000000000049. Review.

PMID:
24441504
8.

Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma.

Li C, Gao Z, Li F, Li X, Sun Y, Wang M, Li D, Wang R, Li F, Fang R, Pan Y, Luo X, He J, Zheng L, Xia J, Qiu L, He J, Ye T, Zhang R, He M, Zhu M, Hu H, Shi T, Zhou X, Sun M, Tian S, Zhou Y, Wang Q, Chen L, Yin G, Lu J, Wu R, Guo G, Li Y, Hu X, Li L, Asan, Wang Q, Yin Y, Feng Q, Wang B, Wang H, Wang M, Yang X, Zhang X, Yang H, Jin L, Wang CY, Ji H, Chen H, Wang J, Wei Q.

Sci Rep. 2015 Oct 27;5:14237. doi: 10.1038/srep14237.

9.

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.

Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, Imielinski M, Hu X, Ling S, Akbani R, Rosenberg M, Cibulskis C, Ramachandran A, Collisson EA, Kwiatkowski DJ, Lawrence MS, Weinstein JN, Verhaak RG, Wu CJ, Hammerman PS, Cherniack AD, Getz G; Cancer Genome Atlas Research Network, Artyomov MN, Schreiber R, Govindan R, Meyerson M.

Nat Genet. 2016 Jun;48(6):607-16. doi: 10.1038/ng.3564. Epub 2016 May 9.

10.

Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?

Vincenten JP, Smit EF, Grünberg K, Postmus PE, Snijders PJ, Witte BI, Heideman DA, Thunnissen E.

Lung Cancer. 2015 Jul;89(1):19-26. doi: 10.1016/j.lungcan.2015.04.005. Epub 2015 Apr 20.

PMID:
25982011
11.

Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.

Kobayashi-Watanabe N, Sato A, Watanabe T, Abe T, Nakashima C, Sueoka E, Kimura S, Sueoka-Aragane N.

Lung Cancer. 2017 Aug;110:35-41. doi: 10.1016/j.lungcan.2017.05.017. Epub 2017 May 25.

PMID:
28676216
12.

Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.

Molitor M, Junker K, Eltze E, Toma M, Denzinger S, Siegert S, Knuechel R, Gaisa NT.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8143-58. eCollection 2015.

13.

Genomics of squamous cell lung cancer.

Rooney M, Devarakonda S, Govindan R.

Oncologist. 2013 Jun;18(6):707-16. doi: 10.1634/theoncologist.2013-0063. Epub 2013 May 31. Review.

14.

Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.

Yang S, Chen L, Chan DW, Li QK, Zhang H.

Clin Proteomics. 2017 Aug 15;14:31. doi: 10.1186/s12014-017-9166-9. eCollection 2017.

15.

Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach.

Bak SH, Park H, Lee HY, Kim Y, Kim HL, Jung SH, Kim H, Kim J, Park K.

Sci Rep. 2018 Feb 19;8(1):3284. doi: 10.1038/s41598-018-21706-1.

16.

Development of Multiple Primary Cancers in Lung Cancer Patients: Appalachian Versus Non-Appalachian Populations of Kentucky.

Pravosud V, Huang B, Tucker T, Vanderford NL.

South Med J. 2017 Dec;110(12):775-781. doi: 10.14423/SMJ.0000000000000742.

PMID:
29197312
17.

Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.

Kim Y, Hammerman PS, Kim J, Yoon JA, Lee Y, Sun JM, Wilkerson MD, Pedamallu CS, Cibulskis K, Yoo YK, Lawrence MS, Stojanov P, Carter SL, McKenna A, Stewart C, Sivachenko AY, Oh IJ, Kim HK, Choi YS, Kim K, Shim YM, Kim KS, Song SY, Na KJ, Choi YL, Hayes DN, Kim J, Cho S, Kim YC, Ahn JS, Ahn MJ, Getz G, Meyerson M, Park K.

J Clin Oncol. 2014 Jan 10;32(2):121-8. doi: 10.1200/JCO.2013.50.8556. Epub 2013 Dec 9.

18.

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for Chinese patients with squamous cell carcinoma of lung harboring EGFR mutation.

Fang W, Zhang J, Liang W, Huang Y, Yan Y, Wu X, Hu Z, Ma Y, Zhao H, Zhao Y, Yang Y, Xue C, Zhang J, Zhang L.

J Thorac Dis. 2013 Oct;5(5):585-92. doi: 10.3978/j.issn.2072-1439.2013.09.15.

19.

Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.

Lo KC, Stein LC, Panzarella JA, Cowell JK, Hawthorn L.

Lung Cancer. 2008 Mar;59(3):315-31. Epub 2007 Oct 29.

PMID:
18029052
20.

Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.

Staaf J, Isaksson S, Karlsson A, Jönsson M, Johansson L, Jönsson P, Botling J, Micke P, Baldetorp B, Planck M.

Int J Cancer. 2013 May 1;132(9):2020-31. doi: 10.1002/ijc.27879. Epub 2012 Oct 20.

Supplemental Content

Support Center